AEM vs CBT

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

Cabot Corporation presents a stable but stagnating profile, evidenced by a Piotroski F-Score of 4/9. While the company maintains strong profitability with an ROE of 21.82% and a consistent track record of earnings beats, it is currently facing significant headwinds with negative YoY revenue (-11.10%) and earnings growth (-18.20%). The stock is trading at a significant premium to both its Graham Number ($62.31) and Intrinsic Value ($40.04), suggesting limited upside potential at current price levels.